BioPlus Acquisition Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioPlus Acquisition Corp. generated cash of -$691,465, which is less than the previous year. Cash used in financing activities reached the amount of $196,225 last year. Net change in cash is therefore -$495,240.
Cash Flow
| 2013 | -54.55M | -302.37M | 295.82M |
|---|---|---|---|
| 2014 | -31.42M | 44.26M | -13.1M |
| 2015 | -64.74M | 13.02M | 66.56M |
| 2016 | -42.77M | -72.98M | 109.74M |
| 2017 | -760K | -13.63M | 44.28M |
| 2018 | -20.1M | -13.52M | 8.07M |
| 2021 | -844 | -255.92K | 257.46K |
| 2022 | -691.46K | 0 | 196.22K |
BIOSU Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 635.54K | 0 | 39.5M | 9.6M | 15.6M | 700K | 1M | 62.1M |
Operating activities | ||||||||
Net income | 1.99M | -152 | -51.7M | -64.2M | -41.5M | -299.7M | -147.5M | -69.7M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 0 | 0 | 23.6M | 27.73M | 21.55M | 22.74M | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.45M |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.45M |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 0 | 0 | 0 | 3M | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 11.35M | -2.54M | 10.01M | -5.76M | -2.95M | 4.93M |
Accounts payable | 0 | 0 | -815K | -4.80M | 2.34M | -6.68M | 5.31M | 22.13M |
Cash generated by operating activities | -691.46K | -844 | -20.1M | -760K | -42.77M | -64.74M | -31.42M | -54.55M |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -13.88M | -8.68M | -9.64M | -11.54M | -13.83M | -282.99M |
Acquisitions Net | 0 | 0 | 0 | 0 | -67.51M | 0 | -454K | 0 |
Cash generated by investing activities | 0 | -255.92K | -13.52M | -13.63M | -72.98M | 13.02M | 44.26M | -302.37M |
Financing activities | ||||||||
Common Stock Issued | 0 | 0 | 0 | 20.77M | 83.26M | 0 | 0 | 118.38M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -60K | 20.9M | 83.07M | 59.64M | 1.47M | 120.93M |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | -1.13M | -5M |
Cash used in financing activities | 196.22K | 257.46K | 8.07M | 44.28M | 109.74M | 66.56M | -13.1M | 295.82M |
Net Change In Cash | -495.24K | 692 | -25.55M | 29.89M | -6.01M | 14.84M | -260K | -61.1M |
Cash at end of period | 140.30K | 692 | 13.95M | 39.49M | 9.59M | 15.54M | 740K | 1M |
| Data source | Data source |